Skip to content

ABAXYS THERAPEUTICS

Active Public limited companyfounded 2015active for 10 yearsRue du Berceau 91, 1495 Villers-la-VilleKBO/BCE: BE 0644.674.965 #4 company by equity in Villers-la-Ville, Professional and technical services sector

Lifetime

10 annual accounts with figures on one time axis
peak of €91,329 in 2025
€91,329▲ €96,792
lowest -€47,942 in 2017
€75,495▲ €91,410
peak of €1.0m in 2025
€1.0m▲ 74.4%
€264,542▼ 58.1%
Board6 names since 2015
3 directors and 2 others
Documentsfilings and deeds
17-08-202617 days late
2025micro format
Gross margin from -€5,463 to €91,329Profit of €75,495, after a loss (managing director) and (director) reappointed 22-08Equity from €598,151 to €1.0mDebts from €630,810 to €264,542Cash from €21,625 to €124,807

Key points

from the 2025 annual accounts

Result

€75,495 €75,495
-€15,9002024€75,5002025

Back in profit in 2025, after a loss of €15,915 in 2024.

Filings

10 annual accounts 9 late
AprilJune31 JulyOctober20202025

The 2020 accounts came in latest, 72 days after the end of the period.

Position in the sector

€1.0m

More equity than 93% of companies in research and development. The sector median is €113,463, over 669 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as ABAXYS THERAPEUTICS has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for ABAXYS THERAPEUTICS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Director, since 27-03-2018
Director, since 30-05-2022
  • deed of 18-11-2021
  • 318 sharesdeed of 18-11-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0644674965
(managing director) and (director) reappointed General meeting of 18h00 · Gazette deed
1 director appointed, 2 resignations and resign · appointed · General meeting of 09-06-2023 · Gazette deed
Capital increase · Amendment of the articles The capital rose from €154,158.72 to €274,158.72, with 1,826 new shares · The capital rose from €274,158.72 to €324,158.72, with 318 new shares · Contribution by ) (€620,000) · General meeting of 29-10-2021 · Gazette deed
All 26 events

Comparable companies

same main activity, similar in size and age
Company
ABAXYS THERAPEUTICS Villers-la-Ville €1.3m €91,329 79.8% -
FENIXGM Fleurus €0.8m €74,920 25.1% -
FRID MIND TECHNOLOGIES Charleroi €1.2m €37,139 70.8% -
Fertiga Lede €2.1m €98,477 95.7% -
Laura Hermans Leuven €1.0m €78,591 20.9% -
CASC8 Keerbergen €0.8m €207,114 74.4% -
COOPSTROOM Bruges €1.8m €34,694 44.4% 3.6

These companies have the same main activity as ABAXYS THERAPEUTICS: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €822,000 and €2.1m, founded between 2012 and 2017.

Official details

Source: KBO
Status
Active since 18-12-2015Normal situation
Activity
Research and development on biotechnologyNACE 72101and 1 other
Establishment unit
2.251.927.7491495 Villers-la-Ville, since 21-03-2016
Financial year end
31 December
Peppol
Reachable since 11-06-2026
Company details

Annual accounts 2025

≈ €270,000estimated
€1.3m▲ 6.4%
Filing
Filed on 17-08-2026
Financials

Insights on ABAXYS THERAPEUTICS

ABAXYS THERAPEUTICS files the micro format. That format states no turnover. The gross margin rose from -€9,618 in 2016 to €91,329 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ABAXYS THERAPEUTICS

What is the company number of ABAXYS THERAPEUTICS?
The company number of ABAXYS THERAPEUTICS is 0644.674.965. The VAT number is the same number with BE in front: BE 0644.674.965.
Where is ABAXYS THERAPEUTICS based?
The registered office is at Rue du Berceau 91, 1495 Villers-la-Ville.Company details
What does ABAXYS THERAPEUTICS do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of ABAXYS THERAPEUTICS?
ABAXYS THERAPEUTICS is a public limited company (NV).
When was ABAXYS THERAPEUTICS founded?
ABAXYS THERAPEUTICS was founded on 18-12-2015.
Is ABAXYS THERAPEUTICS still active?
Yes, ABAXYS THERAPEUTICS is an active enterprise in the KBO register.
What is the turnover of ABAXYS THERAPEUTICS?
The turnover in financial year 2025 is about €270,000. This figure is estimated from the gross margin of €91,329 and 2,981 comparable companies of the same size. It probably lies between €180,000 and €470,000. It is a rough estimate.Financials
Is ABAXYS THERAPEUTICS profitable?
In financial year 2025, ABAXYS THERAPEUTICS made a profit of €75,495.
Where can I find the annual accounts of ABAXYS THERAPEUTICS?
ABAXYS THERAPEUTICS filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ABAXYS THERAPEUTICS due?
ABAXYS THERAPEUTICS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.